tesaglitazar has been researched along with gliclazide in 1 studies
| Studies (tesaglitazar) | Trials (tesaglitazar) | Recent Studies (post-2010) (tesaglitazar) | Studies (gliclazide) | Trials (gliclazide) | Recent Studies (post-2010) (gliclazide) |
|---|---|---|---|---|---|
| 74 | 13 | 25 | 997 | 214 | 308 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chander, R; Chaturvedi, D; Ray, S; Srivastava, AK | 1 |
1 other study(ies) available for tesaglitazar and gliclazide
| Article | Year |
|---|---|
Omega-(2-Naphthyloxy) amino alkanes as a novel class of anti-hyperglycemic and lipid lowering agents.
Topics: Alkanes; Alkylation; Amination; Animals; Hypoglycemic Agents; Hypolipidemic Agents; Lipid Metabolism; Male; Molecular Structure; Naphthalenes; PPAR gamma; Rats; Structure-Activity Relationship | 2008 |